OTC - ACTIVE INGREDIENT SECTION
Influenzinum 8X HPUS
A/Michigan/45/2015 (H1N1) pdm09-like virus
A/Singapore/INFIMH-16–0019/2016 (H3N2)-like virus
B/Maryland/15/2016/ BX-69A (B/Colorado/06/2017-like virus (B/Victoria lineage))
Influenzinum
- Manufacturer
- Boiron | Boiron, Inc.
- Effective date
- 2020-11-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:09:06
Label at a glance#
ProductInfluenzinum
Active ingredientINFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEH..., INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Label structure10 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Relieves after effects of flu or flu-like symptoms
INDICATIONS & USAGE SECTION
Relieves after effects of flu or flu-like symptoms
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use
DOSAGE & ADMINISTRATION SECTION
Unit dose: Dissolve entire contents of the tube under the tongue, repeat as necessary up to 3 times a day
Multi-dose: 5 pellets 3 times a day until symptoms are relieved
SPL UNCLASSIFIED SECTION
Multi-dose:
Do not use if pellet dispenser seal is broken
Approx 80 pellets
These "Uses" have not been evaluated by the FDA
Unit Dose:
Do not use if cap seal is broken or missing
Store at 68-77 degrees F
These "Uses" have not been evaluated by the FDA
INACTIVE INGREDIENT SECTION
lactose, sucrose
OTC - QUESTIONS SECTION
Made in France
Distributed by Boiron Inc.
1-800-BOIRON-1
Newtown Square, PA 19073
info@Boiron.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Influenzinum
- INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- LACTOSE, UNSPECIFIED FORM
- ANHYDROUS LACTOSE
- INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- SUCROSE
- INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)
- INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-2652 | 0220-2652-41, 0220-2652-31 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b9bd4fd3-32f7-e1f7-e053-2a95a90a0eec | 76126c7e-5c1d-3bb5-e053-2a91aa0adc45 | 2021-01-25 | 76126c7e-5c1d-3bb5-e053-2a91aa0adc45 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.